Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential | Markets

The biotech sector has been through a lot in the past five years and it is finally rebounding. One of the most important sectors globally, it is hard to imagine life without biotech companies that provide life-changing drugs. With multiple clinical trials happening, getting FDA approvals and ensuring due diligence, these biotech companies have a lot to juggle. If you are a long-term investor, considering biotech stocks to buy for your portfolio can be a smart move.

The industry is never going to be out of demand. There will always be a product pipeline, more approvals and ongoing research to handle. Biotech stocks are bouncing back, and there is immense potential for the sector. If you can handle a little risk that comes with it, here are the three biotech stocks to keep your eyes on this month.

Biotech Stocks to Buy: Novo Nordisk (NVO)

One of the best biotech stocks to buy this month, Novo Nordisk (NYSE:NVO) has an impressive portfolio of drugs. It has seen massive demand for Wegovy, a hot Glucagon-like peptide 1 (GLP-1,) which has led to a rise in revenue.

It saw a 35% jump in sales for Wegovy, which helps reduce the risk of cardiovascular conditions in obese people. Novo Nordisk already has more than 25,000 people taking the brand each week in the quarter.

Novo Nordisk was already known for its obesity drugs, and…

Source investorplace.com

Advertisement Gaming:   Xbox  |  Xbox Bundles  |  Nintendo  |  Playstation  |  Cards   |   Manor Lords   |   Horizon Forbidden West
FTC: We use income earning affiliate links. More on Sposored links.
Terms of use and third-party services. More here.

Ad Amazon Minecraft the game, plus clothing, toys, and accessories.

Ad Amazon Gaming Laptops, clothing, games and more

Ad Amazon MUSIC Artists Merch Shop

Stay connected throughout the year with official, ongoing Microsoft podcasts.
Microsoft Podcasts Apple | Microsoft podcasts YouTube


Related Posts